Synthetic lethality from the combination of a histone methyltransferase, SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma

Yusuke Toyohara(Japanese Foundation For Cancer Research), Yutaka Osuga(The University of Tokyo)
Research Square
February 7, 2024
Cited by 0


Related Papers